Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
The Journal of Experimental Medicine|May 29, 2013
IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance predictionStéphanie Bibert, Thierry Roger, Thierry Calandra, et al.
The Journal of Biological Chemistry|June 3, 2010
Identification and characterization of novel classes of macrophage migration inhibitory factor (MIF) inhibitors with distinct mechanisms of actionHajer Ouertatani-Sakouhi, Farah El-Turk, Bruno Fauvet, et al.
Blood|October 20, 2010
Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infectionThierry Roger, Jérôme Lugrin, Didier Le Roy, et al.
European Journal of Immunology|February 26, 2013
Lack of Mycobacterium tuberculosis-specific interleukin-17A-producing CD4+ T cells in active diseaseMatthieu Perreau, Virginie Rozot, Hugh C Welles, et al.
Immunopharmacology and Immunotoxicology|October 31, 2014
Oral cyclosporine A in neonatal swines for transplantation studiesHua Pan, Aram Gazarian, Samuel Buff, et al.
The Journal of Endocrinology|June 23, 2010
Macrophage migration inhibitory factor deficiency leads to age-dependent impairment of glucose homeostasis in miceVéronique Serre-Beinier, Christian Toso, Philippe Morel, et al.
Plos One|June 20, 2020
Feasibility of intratumoral 165Holmium siloxane delivery to induced U87 glioblastoma in a large animal model, the Yucatan minipigMehrdad Khoshnevis, Claude Carozzo, Richard Brown, et al.
Plos Pathogens|June 23, 2009
Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasomeJulie Delaloye, Thierry Roger, Quynh-Giao Steiner-Tardivel, et al.
Journal of Virology|January 23, 2015
Interleukin-1- and type I interferon-dependent enhanced immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletions of type I and type II interferon-binding proteinsJulie Delaloye, Abdelali Filali-Mouhim, Mark J Cameron, et al.
Journal of Medical Virology|December 2, 2024
Development of Broad-Spectrum β-Cyclodextrins-Based Nanomaterials Against Influenza VirusesArnaud Charles-Antoine Zwygart, Chiara Medaglia, Yong Zhu, et al.
Pageof 13